Detalhe da pesquisa
1.
Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis.
N Engl J Med
; 381(25): 2429-2439, 2019 12 19.
Artigo
Inglês
| MEDLINE | ID: mdl-31661198
2.
Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis.
N Engl J Med
; 379(17): 1621-1634, 2018 10 25.
Artigo
Inglês
| MEDLINE | ID: mdl-30280651
3.
Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72/AS01 in South African adults.
Am J Respir Crit Care Med
; 188(4): 492-502, 2013 08 15.
Artigo
Inglês
| MEDLINE | ID: mdl-23306546
4.
A randomized, controlled dose-finding Phase II study of the M72/AS01 candidate tuberculosis vaccine in healthy PPD-positive adults.
J Clin Immunol
; 33(8): 1360-75, 2013 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-24142232
5.
Non-clinical evaluation of local and systemic immunity induced by different vaccination strategies of the candidate tuberculosis vaccine M72/AS01.
Tuberculosis (Edinb)
; 143: 102425, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-38180028
6.
Validation of an enzyme-linked immunosorbent assay for the quantification of human IgG directed against the repeat region of the circumsporozoite protein of the parasite Plasmodium falciparum.
Malar J
; 11: 384, 2012 Nov 22.
Artigo
Inglês
| MEDLINE | ID: mdl-23173602
7.
Subsequent AS01-adjuvanted vaccinations induce similar transcriptional responses in populations with different disease statuses.
PLoS One
; 17(11): e0276505, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36355775
8.
An adjuvanted polyprotein HIV-1 vaccine induces polyfunctional cross-reactive CD4+ T cell responses in seronegative volunteers.
Clin Infect Dis
; 52(4): 522-31, 2011 Feb 15.
Artigo
Inglês
| MEDLINE | ID: mdl-21208909
9.
Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants.
N Engl J Med
; 359(24): 2533-44, 2008 Dec 11.
Artigo
Inglês
| MEDLINE | ID: mdl-19064623
10.
Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age.
N Engl J Med
; 359(24): 2521-32, 2008 Dec 11.
Artigo
Inglês
| MEDLINE | ID: mdl-19064627
11.
Evaluation of the safety and immunogenicity of the RTS,S/AS01E malaria candidate vaccine when integrated in the expanded program of immunization.
J Infect Dis
; 202(7): 1076-87, 2010 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-20735271
12.
Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial.
Lancet
; 370(9598): 1543-51, 2007 Nov 03.
Artigo
Inglês
| MEDLINE | ID: mdl-17949807
13.
Long-term safety and immunogenicity of the M72/AS01E candidate tuberculosis vaccine in HIV-positive and -negative Indian adults: Results from a phase II randomized controlled trial.
Medicine (Baltimore)
; 97(45): e13120, 2018 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-30407329
14.
A Randomized, Controlled Safety, and Immunogenicity Trial of the M72/AS01 Candidate Tuberculosis Vaccine in HIV-Positive Indian Adults.
Medicine (Baltimore)
; 95(3): e2459, 2016 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-26817879
15.
Safety and immunogenicity of the M72/AS01E candidate tuberculosis vaccine in adults with tuberculosis: A phase II randomised study.
Tuberculosis (Edinb)
; 100: 118-127, 2016 09.
Artigo
Inglês
| MEDLINE | ID: mdl-27553419
16.
Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial.
Lancet
; 364(9443): 1411-20, 2004.
Artigo
Inglês
| MEDLINE | ID: mdl-15488216
17.
Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic setting.
Vaccine
; 33(32): 4025-34, 2015 Jul 31.
Artigo
Inglês
| MEDLINE | ID: mdl-26072017
18.
Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine when given as a booster to BCG in Gambian infants: an open-label randomized controlled trial.
Tuberculosis (Edinb)
; 94(6): 564-78, 2014 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-25305000
19.
Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine in HIV-infected adults on combination antiretroviral therapy: a phase I/II, randomized trial.
AIDS
; 28(12): 1769-81, 2014 Jul 31.
Artigo
Inglês
| MEDLINE | ID: mdl-24911353
20.
Improved CD4⺠T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis candidate vaccine formulations: a randomized trial.
Vaccine
; 31(17): 2196-206, 2013 Apr 19.
Artigo
Inglês
| MEDLINE | ID: mdl-22643213